Judy George is a Deputy Managing Editor at ABC Network News. She specializes in medicine and healthcare, covering topics such as aging and longevity, diet and nutrition, mental health care, and consumer health. Judy's work has been featured in prominent outlets including Knowledia, Joe Miller for US Senate, MSN, and MedPage Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Judy George's coverage mainly focuses on healthcare, pharmaceuticals, and scientific research. She frequently cites data and reports on government announcements related to health topics. Therefore, she is likely to be responsive to pitches that offer access to new or exclusive data in the healthcare and pharmaceutical sector. Additionally, Judy may be interested in expert analysis or commentary on recent government announcements concerning health-related issues.
Given her extensive coverage of neurological conditions such as dementia and chronic pain, sources with expertise in these areas are likely to appeal to her. If you have insights into innovative treatments or emerging trends within the healthcare industry, particularly those related to neurology or chronic pain management, Judy would likely find them valuable for her reporting.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Judy George
A new APOE -independent multi-ancestry polygenic risk score opens in a new tab or window for Alzheimer's disease was associated with cognitive
Extradited Danish physician admits guilt in operating wire fraud scheme
By: Judy George
Prevalence is rising, and better imaging isn't the whole reason
— Zilganersen targets protein buildup that drives Alexander disease
Analysis offers surprising twist to the smoking-Parkinson's puzzle
By: Judy George
— News and commentary from the world of neurology and neuroscience
By: Judy George
In new patients, disability score changes were similar over 2 years regardless of treatment
Key Takeaways Medicaid beneficiaries with autism lived nearly 14 fewer years than other Americans. They also had higher mortality risk than other Medicaid beneficiaries.
New multiple sclerosis (MS) patients treated with B-cell-depleting drugs or high-efficacy therapies had lower relapse rates and fewer brain lesions
By: Judy George
Motor function may improve with adjunctive apitegromab
